Saito et al., 2000 - Google Patents
Allelic imbalance and mutations of the PTEN gene in ovarian cancerSaito et al., 2000
View PDF- Document ID
- 11427927628258786040
- Author
- Saito M
- Okamoto A
- Kohno T
- Takakura S
- Shinozaki H
- Isonishi S
- Yasuhara T
- Yoshimura T
- Ohtake Y
- Ochiai K
- Yokota J
- Tanaka T
- Publication year
- Publication venue
- International journal of cancer
External Links
Snippet
Abstract The PTEN/MMAC1/TEP1 tumor‐suppressor gene, which maps to chromosome 10q23. 3, is mutated and homozygously deleted in a variety of human tumors, including endometrioid‐type ovarian tumors. We examined 33 primary ovarian cancers and 3 ovarian …
- 108010011536 PTEN Phosphohydrolase 0 title abstract description 102
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for mutation or polymorphism detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saito et al. | Allelic imbalance and mutations of the PTEN gene in ovarian cancer | |
| Brewster et al. | Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma | |
| Effert et al. | Alterations of the p53 gene are associated with the progression of a human prostate carcinoma | |
| Çelebi et al. | Identification of PTEN mutations in metastatic melanoma specimens | |
| Meyers et al. | Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors | |
| Maxwell et al. | Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers | |
| Salhi et al. | Multiple familial trichoepithelioma caused by mutations in the cylindromatosis tumor suppressor gene | |
| Dong et al. | Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients | |
| Pavlovich et al. | Renal tumors in the Birt-Hogg-Dube syndrome | |
| Nassif et al. | PTEN mutations are common in sporadic microsatellite stable colorectal cancer | |
| Liew et al. | High frequency of p16INK4A gene alterations in hepatocellular carcinoma | |
| Minaguchi et al. | PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas | |
| Castells et al. | A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers | |
| Norberg et al. | Increased p53 mutation frequency during tumor progression—results from a breast cancer cohort | |
| Lerebours et al. | Update on inflammatory breast cancer | |
| Cheng et al. | Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas | |
| De Vivo et al. | Novel germline mutations in the PTENtumour suppressor gene found in women with multiple cancers | |
| Auroy et al. | Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect | |
| Barker et al. | Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas | |
| Schenkman et al. | Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors | |
| Saridaki et al. | Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin | |
| Wang et al. | Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas | |
| Cheng et al. | Allelic imbalance in the clonal evolution of prostate carcinoma | |
| Williams et al. | Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer | |
| Wassif et al. | Genetic studies of a family with hereditary hyperparathyroidism–jaw tumour syndrome |